A detailed history of Prosperity Consulting Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 3,580 shares of VRTX stock, worth $1.45 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,580
Previous 892 301.35%
Holding current value
$1.45 Million
Previous $418,000 298.09%
% of portfolio
0.13%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $1.24 Million - $1.36 Million
2,688 Added 301.35%
3,580 $1.66 Million
Q2 2024

Aug 08, 2024

BUY
$392.81 - $485.53 $350,386 - $433,092
892 New
892 $418,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.